vs
Side-by-side financial comparison of AstroNova, Inc. (ALOT) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $39.2M, roughly 1.6× AstroNova, Inc.). AstroNova, Inc. runs the higher net margin — 1.0% vs -70.9%, a 71.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -3.4%). AstroNova, Inc. produced more free cash flow last quarter ($3.3M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 2.1%).
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
ALOT vs CTKB — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.2M | $62.1M |
| Net Profit | $378.0K | $-44.1M |
| Gross Margin | 36.2% | 52.9% |
| Operating Margin | 3.3% | -9.0% |
| Net Margin | 1.0% | -70.9% |
| Revenue YoY | -3.4% | 8.1% |
| Net Profit YoY | 221.5% | -557.1% |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.2M | $62.1M | ||
| Q3 25 | $36.1M | $52.3M | ||
| Q2 25 | $37.7M | $45.6M | ||
| Q1 25 | — | $41.5M | ||
| Q4 24 | $40.4M | $57.5M | ||
| Q3 24 | $40.5M | $51.5M | ||
| Q2 24 | $33.0M | $46.6M | ||
| Q1 24 | $39.6M | $44.9M |
| Q4 25 | $378.0K | $-44.1M | ||
| Q3 25 | $-1.2M | $-5.5M | ||
| Q2 25 | $-376.0K | $-5.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | $240.0K | $9.6M | ||
| Q3 24 | $-311.0K | $941.0K | ||
| Q2 24 | $1.2M | $-10.4M | ||
| Q1 24 | $2.7M | $-6.2M |
| Q4 25 | 36.2% | 52.9% | ||
| Q3 25 | 32.2% | 52.7% | ||
| Q2 25 | 33.6% | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | 33.9% | 58.5% | ||
| Q3 24 | 35.3% | 56.3% | ||
| Q2 24 | 36.3% | 54.6% | ||
| Q1 24 | 31.9% | 51.3% |
| Q4 25 | 3.3% | -9.0% | ||
| Q3 25 | -2.0% | -17.6% | ||
| Q2 25 | 1.5% | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | 3.1% | 5.2% | ||
| Q3 24 | 2.6% | -8.2% | ||
| Q2 24 | 4.1% | -18.3% | ||
| Q1 24 | 9.9% | -23.9% |
| Q4 25 | 1.0% | -70.9% | ||
| Q3 25 | -3.4% | -10.5% | ||
| Q2 25 | -1.0% | -12.2% | ||
| Q1 25 | — | -27.5% | ||
| Q4 24 | 0.6% | 16.8% | ||
| Q3 24 | -0.8% | 1.8% | ||
| Q2 24 | 3.6% | -22.4% | ||
| Q1 24 | 6.8% | -13.8% |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $0.15 | — | ||
| Q1 24 | $0.37 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $76.9M | $341.7M |
| Total Assets | $140.8M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $90.9M | ||
| Q3 25 | $3.9M | $93.3M | ||
| Q2 25 | $5.4M | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | $4.4M | $98.7M | ||
| Q3 24 | $4.8M | $162.3M | ||
| Q2 24 | $4.0M | $177.9M | ||
| Q1 24 | $4.5M | $168.8M |
| Q4 25 | $76.9M | $341.7M | ||
| Q3 25 | $75.8M | $378.6M | ||
| Q2 25 | $76.6M | $377.6M | ||
| Q1 25 | — | $379.6M | ||
| Q4 24 | $92.2M | $395.7M | ||
| Q3 24 | $91.8M | $385.5M | ||
| Q2 24 | $91.2M | $389.1M | ||
| Q1 24 | $90.3M | $392.6M |
| Q4 25 | $140.8M | $461.5M | ||
| Q3 25 | $143.1M | $494.9M | ||
| Q2 25 | $150.3M | $493.3M | ||
| Q1 25 | — | $482.6M | ||
| Q4 24 | $166.5M | $499.5M | ||
| Q3 24 | $169.0M | $491.2M | ||
| Q2 24 | $126.6M | $483.7M | ||
| Q1 24 | $133.3M | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $-771.0K |
| Free Cash FlowOCF − Capex | $3.3M | $-1.8M |
| FCF MarginFCF / Revenue | 8.5% | -2.9% |
| Capex IntensityCapex / Revenue | 0.2% | 1.6% |
| Cash ConversionOCF / Net Profit | 9.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.9M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $-771.0K | ||
| Q3 25 | $249.0K | $-3.9M | ||
| Q2 25 | $4.4M | $108.0K | ||
| Q1 25 | — | $-125.0K | ||
| Q4 24 | $-4.7M | $2.0M | ||
| Q3 24 | $162.0K | $13.2M | ||
| Q2 24 | $6.9M | $6.2M | ||
| Q1 24 | $6.5M | $4.0M |
| Q4 25 | $3.3M | $-1.8M | ||
| Q3 25 | $202.0K | $-4.6M | ||
| Q2 25 | $4.3M | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | $-5.0M | $1.1M | ||
| Q3 24 | $-176.0K | $12.2M | ||
| Q2 24 | $6.4M | $5.2M | ||
| Q1 24 | $6.0M | $3.4M |
| Q4 25 | 8.5% | -2.9% | ||
| Q3 25 | 0.6% | -8.7% | ||
| Q2 25 | 11.5% | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | -12.4% | 1.9% | ||
| Q3 24 | -0.4% | 23.7% | ||
| Q2 24 | 19.5% | 11.0% | ||
| Q1 24 | 15.3% | 7.6% |
| Q4 25 | 0.2% | 1.6% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | 0.6% | 1.6% | ||
| Q3 24 | 0.8% | 2.0% | ||
| Q2 24 | 1.5% | 2.3% | ||
| Q1 24 | 1.0% | 1.3% |
| Q4 25 | 9.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -19.76× | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | 5.85× | — | ||
| Q1 24 | 2.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
